Quality of life following liver transplantation in patients with liver metastases from colorectal carcinoma

Scandinavian Journal of Caring Sciences

Volumn 26, Issue 4, 2012, Pages 713-719

  Andersen, Marit Helen ^a   Dueland, Svein ^a   Hagness, Morten ^a,b   Vidnes, Tone ^a   Finstad, Ellen Drolsum ^a   Wahl, Astrid Klopstad ^c   Foss, Aksel ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Liver metastases from colorectal carcinoma; Liver transplantation; Nonrandomized pilot study; Quality of life

Indexed keywords

ARTICLE; COLORECTAL TUMOR; FEMALE; HUMAN; LIVER TRANSPLANTATION; LIVER TUMOR; MALE; METASTASIS; MIDDLE AGED; NORWAY; PATHOLOGY; PATHOPHYSIOLOGY; PILOT STUDY; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE;

COLORECTAL NEOPLASMS; FEMALE; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NORWAY; PILOT PROJECTS; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 84869080603     PISSN: 02839318     EISSN: 14716712     Source Type: Journal    
DOI: 10.1111/j.1471-6712.2012.00984.x     Document Type: Article

References (25)

1. Ries LAG, Melbert D, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ, Mariotto A, Miller BA, Feuer EJ, Altekruse SF, Lewis DR, Clegg L, Eisner MP, Reichman M (eds). Surveillance, Epidemiology, and End Results (SEER) Cancer Statistics Review, 1975-2005. National Cancer Institute, Bethesda, MD. http://seer.cancer.gov/csr/1975_2005/ (last accessed 9 March 2012).
2. American Cancer Society. Colorectal Cancer Facts & Figures 2011-2013. 2011, American Cancer Society, Atlanta, GA.
3. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJCancer statistics, 2009. CA A Cancer J Clin 2009; 59: 225-49.
4. Sobrero AF, Maurel J, Fehrenbacher L, Scheithauer W, Abubakr YA, Lutz MP, Vega-Villegas ME, Eng C, Steinhauer EU, Prausova J, Lenz H-J, Borg C, Middleton G, Kröning H, Luppi G, Kisker O, Zubel A, Langer C, Kopit J, Burris HAEPIC: Phase III trial of cetuximab pus irinotecan after fluoropyrimidine and oxaliplatin failure in patients with metastatic colorctal cancer. J Clin Oncol 2008; 26: 2311-9.
5. Tournigand C, André T, Achille E, Lledo G, Flesh M, Mery-Mignard D, Quinaux E, Couteau C, Buyse M, Ganem G, Landi B, Colin P, Louvet C, de Gramont AFOLFIRI Followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 2004; 15: 229-37.
6. Onaca N, Davis GL, Goldstein RM, Jennings LW, Klintmalm GBExpanded criteria for liver transplantation in patients with hepatocellular carcinoma: a report from the international registry of hepatic tumors in liver transplantation. Liver Transplant 2007; 13: 391-9.
7. European Liver Transplant Registry (ELTR) 2009http://www.eltr.org (last accessed 9 September 2011).
8. Fahy BN, Jarnagin WR. Evolving techniques in the treatment of liver colorectal metastases: role of laparoscopy, radiofrequency, ablation, microwave coagulation, hepatic arterial chemotherapy, indications and contraindications for resection, role of transplantation, and timing of chemotherapy. Surg Clin N Am 2006; 86: 1005-22.
9. Kappel S, Kandioler D, Steininger R, Längle F, Wrba F, Ploder M, Berlakovich G, Soliman T, Hetz H, Rockenschaub S, Roth E, Mühlbacher FGenetic detection of lymph node micrometastases: a selection criterion for liver transplantation in patients with liver metastases after colorectal cancer. Transplantation 2006; 81: 64-70.
10. Hoti E, Adam R. Liver transplantation for primary metastatic liver cancers. Transplant Int 2008; 21: 1107-17.
11. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JCThe European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Nat Cancer Institu 1993; 85: 365-76.
12. Fayers P, Aaronson N, Bjordal K, Groenvold M, Curran D, Bottomley AEORTC Scoring Manual, 2nd edn. 1999 EORTC Quality of Life Study Group, Brussels, Belgium.
13. Kaasa S, Bjordal K, Aaronson N, Moum T, Wist E, Hagen S, Kvikstad A, The EORTC Study Group on Quality of Life. The EORTC core quality of life questionnaire (QLQ-C30): validity and reliability when analysed with patients treated with palliative radiotherapy. Eur J Cancer 1995; 31A: 2260-3.
14. Fayers P, Hays R. Assessing quality of life in clinical trials, 2nd edn. 2005, Oxford University Press, New York.
15. Fayers PM, Machin D. Quality of life. Assessment, analysis and interpretation. 2000, John Wiley & Sons Ltd, Chichester.
16. Jonker DJ, O'Callaghan CJ, Karapetis CS, Zalcberg JR, Tu D, Au H-J, Berry SR, Krahn M, Price T, Simes RJ, Tebbutt NC, van Hazel G, Wierzbicki R, Langer C, Moore MJCetuximab for the treatment of colorectal cancer. New Engl J Med 2007; 357: 2040-8.
17. Siena S, Peeters M, Van Cutsem E, Humblet Y, Conte P, Bajetta E, Comandini D, Bodoky G, van Hazel G, Salek T, Wolf M, Devercelli G, Wolley M, Amado RGAssociation of progression-free survival with patient-reported outcomes and survival: results from a randomized phase 3 trial of panitumumab. Brit J Cancer 2007; 97: 1469-74.
18. Au H-J, Karapetis CS, O'Callaghan CJ, Tu D, Moore MJ, Zalcberg JR, Kennecke H, Shapiro JD, Koski S, Pavlakis N, Charpentier D, Wyld D, Jefford M, Knight GJ, Magoski NM, Brundage MD, Jonker DJHealth-related quality of life in patients with advanced colorectal cancer treated with cetuximab: overall and KRAS-specific results of the NCIC CTG and AGITG CO.17 trial. J Clin Oncol 2009; 27: 1822-8.
19. Langenhoff BS, Krabbe PFM, Peerenboom L, Wobbes T, Ruers TJMQuality of life after surgical treatment of colorectal liver metastases. Brit J Surg 2006; 93: 1007-14.
20. Kabbinavar FF, Wallace JF, Holmgren E, Yi J, Cella D, Yost KJ, Hurwitz HIHealth-related quality of life impact of bevacizumab when combined with irinotecan, 5-fluorouracil, and leucovorin or 5- fluorouracil and leucovorin for metastatic colorectal cancer. Oncologist 2008; 13: 1021-9.
21. Fosså S, Hess SL, Dahl AA, Hjermestad MJ, Veensrea M. Stability of health-related quality of life in the Norwegian general population and impact oc chronic morbidity in individuals with and without a cancer diagnosis. Acta Oncol 2007; 46: 452-61.
22. Guren MG, Wiig JN, Dueland S, Tveit KM, Fosså SD, Waehre H, Giercksky KEQuality of life in patients with urinary diversion after operation for locally advanced rectal cancer. Eur J Surg Oncol 2001; 27: 645-51.
23. Guren MG, Eriksen MT, Wiig JN, Carlsen E, Nesbakken A, Sigurdsson HK, Wibe A, Tveit KMQuality of life and rectal functional outcome following anterior or abdominalperineal resection for rectal cancer. Eur J Surg Oncol 2005; 31: 735-42.
24. Toso C, Meeberg GA, Bigam DL, Oberholzer J, Shapiro AMJ, Gutfreund K, Ma MM, Mason AL, Wong WWS, Bain VG, Kneteman NMDe Novo Sirolimus-based immunosuppression after liver transplantation for hepatocellular carcinoma: long-term outcomes and side effects. Transplantation 2007; 83: 1162-8.
25. Kugler C, Fischer S, Gottlieb J, Tegtbur U, Welte T, Goerler H, Simon A, Haverich A, Strueber MSymptom experience after lung transplantation: impact on quality of life and adherence. Clin Transplant 2007; 21: 590-6.